Table 3 Predictive factors of AA treatment duration

Age

<60 vs

1

0.107

> = 60

0.57 95% CI [0.29-1.13]

Gleason score

4-6

1

7

1.24 95% CI [0.45-3.39]

0.68

8-10

1.16 95% CI [0.44-3.05]

0.76

Duration of CT before AA treatment

<=4 months

1

]4-6]

0.99 95% [0.42-2.31]

0.98

[6-9]

2.00 95% [0.81-4.98]

0.13

>9

1.17 95% [0.53-2.59]

0.70

PSA baseline before CT

Continuous variable

0.99 95% [0.99-1.00]

0.10

PSA baseline before AA

Continuous variable

1.00 95% [0.99-1.00]

0.67

Sites of metastasis

Bone or visceral alone vs Multiple

1

0.17

1

0.65 95% CI [0.36-1.19]

0.71 95% [0.35-1.44]

0.34

Number of CT lines

1

1

2

1.02 95% [0.53-1.99]

0.94

3

1.23 95% [0.33-4.56]

0.75

4-5

0.26 95% [0.02-4.34]

0.35

PSA variation at 3 months

Decrease

1

<0.0001

1

Increase

0.06 95% [0.02-0.19]

0.13 95% [0.06-0.31]

<0.0001